免疫缺陷模型
免疫缺陷模型是指由于先天遗传突变或者用人工方法造成的免疫系统上一种或者多种免疫成分存在缺陷或者缺失的小鼠，赛业生物自研C‑NKG重度免疫缺陷小鼠，缺失成熟T/B/NK细胞，利于各类人源细胞、肿瘤移植，适配多类科研，已有四十余篇客户引用文献。
免疫缺陷模型
赛业生物提供C-NKG等免疫缺陷小鼠模型，支持肿瘤移植、免疫机制、干细胞移植及药物研究。不同品系的免疫缺陷特征有所差异，可根据移植物类型、研究目的及免疫细胞需求选择模型；如需特殊遗传背景，可进一步了解动物模型定制服务 。
C-NKG重度免疫缺陷小鼠 是在NOD-Scid背景上敲除Il2rg基因构建的品系，缺乏成熟T、B和NK细胞，可用于CDX、PDX及人源细胞和组织移植。以人造血干细胞（HSC）或外周血单个核细胞（PBMC）开展重建的研究，可进一步查看免疫系统人源化重建模型 。
免疫缺陷模型列表
| 产品编号 | 产品名称 | 品系背景 | 应用领域 | 订购 |
|---|
暂无数据
免疫缺陷模型验证数据
1. C‑NKG小鼠B、T和NK细胞检测
2. AG129小鼠免疫细胞检测
衔接肿瘤模型与药效评价
围绕肿瘤移植及候选药物研究，可进一步了解肿瘤药效评价服务 ，结合移植物类型、模型免疫背景和实验终点沟通方案。
免疫缺陷模型精选文献
Proteasome‑guided haem signalling axis contributes to T cell exhaustion
Nature（2026）丨C‑NKG
RPSA‑OLFM4 axis governs neutrophil migration against bacterial infection and sepsis
Nature Communications（2026）丨C‑NKG
KLRG1 silencing increases the efficacy of CAR NK cell therapy against colon cancer via SHP‑2/ZAP‑70/NF‑κB signal pathway
Journal of Translational Medicine（2026）丨C‑NKG
PER2 knockdown drives immunotherapy resistance in gastric cancer via metabolic reprogramming of myeloid‑derived suppressor cells
Cancer & Metabolism（2026）丨huPBMC‑C‑NKG
Hantaan virus infection induces human mucosal‑associated invariant T cell pyroptosis through IRE1α pathway
Communications Biology（2025）丨huPBMC‑C‑NKG
Amplifying antigen‑induced cellular responses with proximity labelling
Nature（2025）丨huPBMC‑C‑NKG
An epitope‑directed mRNA vaccine inhibits tumor metastasis through the blockade of MICA/B α1/2 shedding
Cell Reports Medicine（2025）丨huPBMC‑C‑NKG
Identification and validation of intratumoral microbiome associated with sensitization to immune checkpoint inhibitors
Cell Reports Medicine（2025）丨huPBMC‑C‑NKG
Multidimensional mapping of stimulation‑responsive regulatory elements and candidate causal variants in T cell activation
Science Advances（2025）丨C‑NKG
A Gremlin 1‑expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway
Nature Cancer（2025）丨C‑NKG
DHX34 deficiency triggers tumor‑intrinsic immunity via a dsRNA‑mediated type I interferon pathway activation in HCC
Neoplasia（2025）丨C‑NKG
Tumor microenvironment‑associated oxidative stress impairs SIRT1 secretion to suppress anti‑tumor immune response
Cell Reports（2025）丨C‑NKG
Inhibition of PINK1 senses ROS signaling to facilitate neuroblastoma cell pyroptosis
Autophagy（2025）丨C‑NKG
Interleukin‑33 (IL‑33) promotes DNA damage‑resistance in lung cancer
Cell Death & Disease（2025）丨C‑NKG
Preclinical evaluation of CAR‑T cell immunotherapy with a fully human EpCAM‑specific scFv against pancreatic cancer
Cancer Immunology, Immunotherapy（2025）丨C‑NKG
Human Immune System Reconstitution in NOD/Shi‑Prkdcscid Il2rgem1/Cyagen Mice to Study HIV Infection: Challenges and Pitfalls
Life（2025）丨C‑NKG
Single‑cell data‑driven design of armed oncolytic virus to boost cooperative innate‑adaptive immunity against cancer
Molecular Therapy（2025）丨C‑NKG
A novel HVEM‑Fc recombinant protein for lung cancer immunotherapy
Journal of Experimental & Clinical Cancer Research: CR（2025）丨C‑NKG
Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21‑P27KIP1‑mTOR axis
The EMBO Journal（2025）丨C‑NKG
SERINC2‑mediated serine metabolism promotes cervical cancer progression and drives T cell exhaustion
International Journal of Biological Sciences（2025）丨C‑NKG
A self‑activated and protective module enhances the preclinical performance of allogeneic anti‑CD70 CAR‑T cells
Frontiers in Immunology（2025）丨C‑NKG
FOS‑driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1‑FGFR2‑HIF1 axis
Theranostics（2025）丨C‑NKG
A Novel 167‑Amino Acid Protein Encoded by CircPCSK6 Inhibits Intrahepatic Cholangiocarcinoma Progression via IKBα Ubiquitination
Advanced Science（2025）丨C‑NKG
YTHDC1 negatively regulates UBE3A to influence RAD51 ubiquitination and inhibit apoptosis in colorectal cancer cells
Scientific Reports（2025）丨C‑NKG
Temporal responsive vesicle‑INFγ aptamer‑PEI/HA system targeted activation of B‑CD4T‑Tfh‑CD8T cells cascade inhibits TNBC progression
Nano Today（2025）丨huHSC‑C‑NKG
LncRNA TCL6 regulates miR‑876–5p/MYL2 axis to suppress breast cancer progression
Translational Oncology（2025）丨huHSC‑C‑NKG
相关资料
产品和服务推荐
填写下方表单，预约技术专家一对一沟通
